{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:34:58Z","timestamp":1791516898909,"version":"4.3.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,30]],"date-time":"2023-12-30T00:00:00Z","timestamp":1703894400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Pathogenesis and Therapy"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.cpt.2023.12.004","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:26:06Z","timestamp":1704327966000},"page":"205-211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Gene mutations in newly diagnosed multiple myeloma patients detected by next-generation sequencing technology"],"prefix":"10.1016","volume":"2","author":[{"given":"Yutong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengzhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minqiu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2923-6880","authenticated-orcid":false,"given":"Li","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpt.2023.12.004_bib1","first-page":"2834","article-title":"Burden of multiple myeloma in China: an analysis of the Global Burden of Disease, Injuries, and Risk Factors Study 2019","volume":"136","author":"Liu","year":"2023","journal-title":"Chin Med J"},{"key":"10.1016\/j.cpt.2023.12.004_bib2","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/jama.2022.0003","article-title":"Diagnosis and management of multiple myeloma: a review","volume":"327","author":"Cowan","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.cpt.2023.12.004_bib3","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1182\/blood-2018-03-840132","article-title":"Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma","volume":"132","author":"Walker","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.cpt.2023.12.004_bib4","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/s41375-018-0362-z","article-title":"The future of myeloma precision medicine: integrating the compendium of known drug resistance mechanisms with emerging tumor profiling technologies","volume":"33","author":"Harding","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.cpt.2023.12.004_bib5","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1038\/s41375-018-0037-9","article-title":"Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups","volume":"32","author":"Bolli","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.cpt.2023.12.004_bib6","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1200\/JCO.2014.59.1503","article-title":"Mutational spectrum, copy number changes, and outcome: results of a sequencing study of patients with newly diagnosed myeloma","volume":"33","author":"Walker","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cpt.2023.12.004_bib7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41375-018-0196-8","article-title":"A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis","volume":"33","author":"Walker","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.cpt.2023.12.004_bib8","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cpt.2023.12.004_bib9","first-page":"588","article-title":"Cytogenetics in the management of multiple myeloma: an update by the Groupe francophone de cytog\u00e9n\u00e9tique h\u00e9matologique (GFCH)","volume":"74","author":"Daudignon","year":"2016","journal-title":"Ann Biol Clin (Paris)"},{"key":"10.1016\/j.cpt.2023.12.004_bib10","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.cpt.2023.12.004_bib11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2147\/TACG.S262866","article-title":"Genetic predictors of mortality in patients with multiple myeloma","volume":"14","author":"Hassan","year":"2021","journal-title":"Appl Clin Genet"},{"key":"10.1016\/j.cpt.2023.12.004_bib12","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1038\/s41375-020-0921-y","article-title":"Genome instability in multiple myeloma","volume":"34","author":"Neuse","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.cpt.2023.12.004_bib13","doi-asserted-by":"crossref","DOI":"10.1177\/15330338221111228","article-title":"Comparison of clinical characteristics and genetic aberrations of plasma cell disorders in Thailand population","volume":"21","author":"Jirabanditsakul","year":"2022","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.cpt.2023.12.004_bib14","doi-asserted-by":"crossref","first-page":"9999","DOI":"10.2147\/OTT.S216289","article-title":"Mutations in thirty hotspot genes in newly diagnosed Chinese multiple myeloma patients","volume":"12","author":"Hu","year":"2019","journal-title":"OncoTargets Ther"},{"key":"10.1016\/j.cpt.2023.12.004_bib15","first-page":"166","article-title":"Gene mutation and overexpression of newly diagnosed multiple myeloma patients","volume":"30","author":"Fan","year":"2022","journal-title":"J Exp Hematol"},{"key":"10.1016\/j.cpt.2023.12.004_bib16","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.3324\/haematol.2010.023697","article-title":"Mutations in TP53 are exclusively associated with del(17p) in multiple myeloma","volume":"95","author":"Lode","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.cpt.2023.12.004_bib17","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1182\/blood-2018-10-880831","article-title":"High subclonal fraction of 17p deletion is associated with poor prognosis in multiple myeloma","volume":"133","author":"Thakurta","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.cpt.2023.12.004_bib18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1126\/science.1104905","article-title":"Spindle multipolarity is prevented by centrosomal clustering","volume":"307","author":"Quintyne","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.cpt.2023.12.004_bib19","doi-asserted-by":"crossref","first-page":"8","DOI":"10.6004\/jnccn.2022.0002","article-title":"NCCN Guidelines\u00ae Insights: Multiple Myeloma, Version 3.2022","volume":"20","author":"Callander","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.cpt.2023.12.004_bib20","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1182\/blood-2013-05-504340","article-title":"Mutation of NRAS but not KRAS significantly reduces myeloma sensitivity to single-agent bortezomib therapy","volume":"123","author":"Mulligan","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.cpt.2023.12.004_bib21","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood.2019003382","article-title":"Biological and clinical significance of dysplastic hematopoiesis in patients with newly diagnosed multiple myeloma","volume":"135","author":"Maia","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.cpt.2023.12.004_bib22","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.chembiol.2023.05.004","article-title":"Investigating the NRAS 5' UTR as a target for small molecules","volume":"30","author":"Balaratnam","year":"2023","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.cpt.2023.12.004_bib23","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41467-017-00296-y","article-title":"Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing","volume":"8","author":"Rasche","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.cpt.2023.12.004_bib24","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41571-021-00593-y","article-title":"Single-cell profiling of tumour evolution in multiple myeloma - opportunities for precision medicine","volume":"19","author":"Dutta","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.cpt.2023.12.004_bib25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","article-title":"Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the association for molecular pathology, American society of clinical oncology, and college of American pathologists","volume":"19","author":"Li","year":"2017","journal-title":"J Mol Diagn"}],"updated-by":[{"DOI":"10.1016\/j.cpt.2024.09.002","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000}}],"container-title":["Cancer Pathogenesis and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949713223001076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949713223001076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T20:00:34Z","timestamp":1729022434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949713223001076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S2949713223001076"],"URL":"https:\/\/doi.org\/10.1016\/j.cpt.2023.12.004","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.cpt.2024.09.002","asserted-by":"object"}]},"ISSN":["2949-7132"],"issn-type":[{"value":"2949-7132","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene mutations in newly diagnosed multiple myeloma patients detected by next-generation sequencing technology","name":"articletitle","label":"Article Title"},{"value":"Cancer Pathogenesis and Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpt.2023.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of Chinese Medical Association (CMA).","name":"copyright","label":"Copyright"}]}}